A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Vincent Ribrag, Seung Tae Lee, David Rizzieri, Martin J.S. Dyer, Luis Fayad, Razelle Kurzrock, Leslie Andritsos, Reda Bouabdallah, Amjad Hayat, Larry Bacon, Yu Jiang, Kowser Miah, Bruno Delafont, Oday Hamid, Stephanie Anyanwu, Pablo Martinez, Brian Hess

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences